Targeting kidney disease in type 1 diabetes: progress and promise
ABSTRACT Introduction Chronic kidney disease (CKD) affects ~30–40% of people living with type-1 diabetes (T1D) and remains a major driver of cardiovascular morbidity, kidney-failure, and premature mortality. Despite advances in diabetes-technologies, kidney-protective pharmacotherapy in T1D has remained largely unchang...